Newsfeed : NYC Clinics Halt OraQuick Oral HIV Testing

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » June 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 18, 2008

NYC Clinics Halt OraQuick Oral HIV Testing

The rate of false HIV-positive results using oral fluid specimens with the OraQuick Advance Rapid HIV 1/2 test in New York City rose as high as 1.1 percent over the past eight months, causing the city’s Bureau of STD Control clinics to suspend saliva-based screening with the assay on May 27, Bloomberg reports (bloomberg.com, 6/16).

According to the article, however, OraQuick has proven successful nationwide, with a 0.2 percent false-positive rate over the past 17 months at 400 testing sites across the country.

“What’s happening in New York City appears to be a slight aberration,” said Ron Ticho, a spokesperson from Orasure Technologies, Inc., which developed, manufactures and markets the rapid test. “Performance results may fall slightly outside the expected range for a short period of time. That’s expected.”

HIV testing sites continue to use OraQuick to screen blood samples, and Bloomberg reports that the test's manufacturer, Orasure, is working with the Centers for Disease Control and Prevention and New York health officials to determine why the rate of false positives in the city is higher than the national average. False-negative aberrations have not been reported.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dave41
    Bethany
    Oklahoma


    mtaj0818
    Washington
    DC


    jimmy807
    San Antonio
    Texas

This could be you!
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.